Literature DB >> 11724842

Efficient extraction of virus DNA by NucliSens Extractor allows sensitive detection of hepatitis B virus by PCR.

E Gobbers1, T A Oosterlaken, M J van Bussel, R Melsert, A C Kroes, E C Claas.   

Abstract

The NucliSens Extractor is an automated nucleic acid isolation system based on guanidinium thiocyanate (GuSCN)-silica extraction technology. The system has been validated for the isolation of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) RNAs from human samples in combination with nucleic acid sequence-based amplification- and reverse transcription-PCR-based methods. We evaluated the extractor for hepatitis B virus (HBV) DNA extraction from human samples using a noncommercial HBV DNA PCR. Several sample pretreatment procedures in combination with the extractor were compared with the Qiagen extraction method, and the impact of the sample volume used in the extraction on the sensitivity was investigated. Heating of the lysed sample prior to extractor isolation and the use of a large sample volume resulted in highly sensitive detection of HBV DNA. Incubation of a 1-ml sample in GuSCN at 80 degrees C (10 min) and at 37 degrees C (30 min) allowed detection of 4 and 40 HBV genome equivalents/ml, respectively, in standard dilution panels. Sample lysis in GuSCN at room temperature and proteinase K treatment prior to use of the extractor were less efficient procedures. All clinical samples that were PCR positive after Qiagen extraction and/or that were HBsAg positive were also PCR positive after extractor isolation. HBV DNA, HCV RNA, and HIV type 1 RNA were efficiently coextracted from a single sample, allowing reliable detection of viral genomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724842      PMCID: PMC88546          DOI: 10.1128/JCM.39.12.4339-4343.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.

Authors:  M Omata; T Ehata; O Yokosuka; K Hosoda; M Ohto
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 3.  Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Authors:  R P Beasley
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

4.  A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.

Authors:  B van Gemen; R van Beuningen; A Nabbe; D van Strijp; S Jurriaans; P Lens; T Kievits
Journal:  J Virol Methods       Date:  1994-09       Impact factor: 2.014

5.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

6.  Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand.

Authors:  W H Gerlich; W S Robinson
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

7.  Quantitation of hepatitis B virus genomic DNA by real-time detection PCR.

Authors:  A Abe; K Inoue; T Tanaka; J Kato; N Kajiyama; R Kawaguchi; S Tanaka; M Yoshiba; M Kohara
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

8.  Rapid purification of hepatitis B virus DNA from serum.

Authors:  R Boom; C J Sol; R Heijtink; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

9.  Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.

Authors:  W K Roth; M Weber; E Seifried
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

10.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Authors:  G B Schreiber; M P Busch; S H Kleinman; J J Korelitz
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

View more
  5 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G.

Authors:  Tania M Welzel; Wendell J Miley; Thomas L Parks; James J Goedert; Denise Whitby; Betty A Ortiz-Conde
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  An improved method for the isolation of hepatitis B virus DNA from human serum.

Authors:  Harish Changotra; Prabodh K Sehajpal
Journal:  Indian J Virol       Date:  2013-08-08

4.  Fully automated, internally controlled quantification of hepatitis B Virus DNA by real-time PCR by use of the MagNA Pure LC and LightCycler instruments.

Authors:  Victoria Leb; Markus Stöcher; Elizabeth Valentine-Thon; Gabriele Hölzl; Harald Kessler; Herbert Stekel; Jörg Berg
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 5.  Bio-banking in microbiology: from sample collection to epidemiology, diagnosis and research.

Authors:  Paolo De Paoli
Journal:  FEMS Microbiol Rev       Date:  2005-02-26       Impact factor: 16.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.